Recent posts
CRISPR-based technology presents great opportunities within the field of diagnostics. Learn more with this guide to next-generation diagnostics using CRISPR.
Read more
SUNNYVALE, Calif., June 30, 2021, Gener8 LLC (“Gener8”), a provider of full product lifecycle engineering and manufacturing solutions for highly complex instruments and products within the life sciences and medical device markets, together with its capital partner, Sverica Capital Management LP, is restructuring its 15,000 sq. ft. Carlsbad facility to provide microfluidics cartridge design,…
Read more
In the following blog, we interviewed Gener8’s Director of Engineering, David Nilson, to see how he and his team help promote collaboration and position our engineers as top commercialization experts. In an industry where regulations are evolving, technology is advancing at breakneck speeds, and the marketplace is more competitive than…
Read more
SUNNYVALE, Calif., June 17, 2021 — Gener8 LLC (“Gener8”), a provider of full product lifecycle engineering and manufacturing solutions for highly complex instruments and products within the life sciences and medical device markets, together with its capital partner, Sverica Capital Management LP, announced today that it has expanded its services…
Read more
If you want high-quality products, you need high-quality partners. Discover the importance of working with an ISO 13485 certified company ahead.
Read more